— Know what they know.
Not Investment Advice

DRTS

Alpha Tau Medical Ltd.
1W: +0.9% 1M: -7.3% 3M: +39.7% YTD: +46.4% 1Y: +176.2% 3Y: +154.3% 5Y: -26.7%
$6.92
+0.00 (+0.00%)
After Hours: $7.72 (+0.80, +11.63%)
Weekly Expected Move ±7.9%
$6 $6 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · $609.0M · Alpha Radar Sell · Power 36
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$609.0M
52W Range2.3-8.6
Volume166,005
Avg Volume354,329
Beta1.03
Dividend
Analyst Ratings
3 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOUzi Sofer
Employees125
SectorHealthcare
IndustryBiotechnology
IPO Date2021-03-08
5 Kiryat Hamada Street
Jerusalem 9777605
IL
972 3 577 4115
About Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Recent Insider Trades

NameTypeSharesPriceDate
Avruch Michael 0 2026-03-18
Avruch Michael 0 2026-03-18
Avruch Michael 0 2026-03-18
Avruch Michael 15,527 $6.41 2026-03-18
KIDRON NADAV 0 2026-03-18

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms